← Eichor
Study identifier: NCT07456878 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas

Condition: Pituitary Adenoma  ·  Sponsor: Mayo Clinic

PhasePhase 1
Planned participants5
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of this research is to evaluate the diagnostic role and clinical efficacy of investigational FET-PET/MRI in detecting MRI-occult primary or residual/recurrent functional pituitary adenomas (PAs) and its influence on clinical and surgical decisions.

This description comes directly from the study's public registry record.

Talk to the study team

Julia Santos  ·  904-953-3280  ·  santos.julia@mayo.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Mayo ClinicJacksonville, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07456878